85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details
臨床試験数 : 598 / 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02460588 (ClinicalTrials.gov) | December 2015 | 16/3/2015 | Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis | Cyclophosphamide Added to Corticosteroid in the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Placebo-controlled Randomized Trial | Idiopathic Pulmonary Fibrosis | Drug: Cyclophosphamide;Drug: Placebo;Drug: Corticosteroid (prednisolone) | Assistance Publique - Hôpitaux de Paris | NULL | Completed | 18 Years | N/A | All | 120 | Phase 3 | France |
| 2 | EUCTR2010-023828-24-GB (EUCTR) | 09/06/2011 | 27/04/2011 | The effect of Thalidomide on sputum biomarkers in IPF cough. - The effect of Thalidomide on sputum biomarkers in IPF cough | The effect of Thalidomide on sputum biomarkers in IPF cough. - The effect of Thalidomide on sputum biomarkers in IPF cough | Cough in Idiopathic Pulmonary fibrosis. | Trade Name: Thalidomide Pharmion Product Name: Thalidomide Pharmion Trade Name: PREDNISOLONE Product Name: prednisolone | University of Nottingham | NULL | Not Recruiting | Female: yes Male: yes | United Kingdom |